Aripiprazole Patent Expiration
Aripiprazole is used for acute treatment of manic and mixed episodes associated with bipolar I disorder, adjunctive treatment of major depressive disorder (MDD), and treatment of schizophrenia. It was first introduced by Otsuka Pharmaceutical Co Ltd
Aripiprazole Patents
Given below is the list of patents protecting Aripiprazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Abilify | US5006528 | Carbostyril derivatives |
Oct 20, 2014
(Expired) | Otsuka |
| Abilify | US5006528 | Carbostyril derivatives |
Oct 20, 2014
(Expired) | Otsuka |
| Abilify |
US5006528 (Pediatric) | Carbostyril derivatives |
Apr 20, 2015
(Expired) | Otsuka |
| Abilify |
US5006528 (Pediatric) | Carbostyril derivatives |
Apr 20, 2015
(Expired) | Otsuka |
| Abilify | US6977257 | Aripiprazole oral solution |
Apr 24, 2022
(Expired) | Otsuka |
| Abilify |
US6977257 (Pediatric) | Aripiprazole oral solution |
Oct 24, 2022
(Expired) | Otsuka |
| Abilify | US7053092 | 5-HT1a receptor subtype agonist |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify | US7053092 | 5-HT1a receptor subtype agonist |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify | US7115587 | Aripiprazole complex formulation and method |
Jul 21, 2024
(Expired) | Otsuka |
| Abilify |
US7115587 (Pediatric) | Aripiprazole complex formulation and method | Jan 21, 2025 | Otsuka |
| Abilify | US7550445 | Aripiprazole complex formulation and method |
Jul 21, 2024
(Expired) | Otsuka |
| Abilify |
US7550445 (Pediatric) | Aripiprazole complex formulation and method | Jan 21, 2025 | Otsuka |
| Abilify | US8017615 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Jun 16, 2024
(Expired) | Otsuka |
| Abilify |
US8017615 (Pediatric) | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | Dec 16, 2024 | Otsuka |
| Abilify | US8518421 | Flashmelt oral dosage formulation |
Jan 24, 2021
(Expired) | Otsuka |
| Abilify |
US8518421 (Pediatric) | Flashmelt oral dosage formulation |
Jul 24, 2021
(Expired) | Otsuka |
| Abilify | US8580796 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify |
US8580796 (Pediatric) | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Mar 25, 2023
(Expired) | Otsuka |
| Abilify | US8642600 | Method of treating autism |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify | US8642600 | Method of treating autism |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify |
US8642600 (Pediatric) | Method of treating autism |
Jul 28, 2022
(Expired) | Otsuka |
| Abilify |
US8642600 (Pediatric) | Method of treating autism |
Jul 28, 2022
(Expired) | Otsuka |
| Abilify | US8642760 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify |
US8642760 (Pediatric) | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Mar 25, 2023
(Expired) | Otsuka |
| Abilify | US8759350 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | Mar 02, 2027 | Otsuka |
| Abilify | US8759350 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | Mar 02, 2027 | Otsuka |
| Abilify | US9089567 | Method of treating cognitive impairments and schizophrenias |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify | US9125939 | Carbostyril derivatives and mood stabilizers for treating mood disorders | Jul 28, 2026 | Otsuka |
| Abilify | US9358207 | Flashmelt oral dosage formulation |
Apr 12, 2020
(Expired) | Otsuka |
| Abilify | US9359302 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify | US9387182 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
Dec 25, 2023
(Expired) | Otsuka |
| Abilify | US9387182 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
Dec 25, 2023
(Expired) | Otsuka |
| Abilify Asimtufii | US10517951 | Injectable preparation | Apr 23, 2033 | Otsuka |
| Abilify Asimtufii | US11097007 | Injectable preparation | Apr 23, 2033 | Otsuka |
| Abilify Asimtufii | US11638757 | Injectable preparation | Apr 23, 2033 | Otsuka |
| Abilify Asimtufii | US8338427 | Methods for administering aripiprazole | Mar 15, 2025 | Otsuka |
| Abilify Asimtufii | US8338428 | Methods for administering aripiprazole |
Aug 06, 2023
(Expired) | Otsuka |
| Abilify Asimtufii | US8399469 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | Jun 29, 2025 | Otsuka |
| Abilify Asimtufii | US8759351 | Methods for administering aripiprazole |
Aug 06, 2023
(Expired) | Otsuka |
| Abilify Maintena Kit | US10525057 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Mar 08, 2034 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US10980803 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Sep 24, 2033 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US11154553 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Sep 24, 2033 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US11344547 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Sep 24, 2033 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US11400087 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Sep 24, 2033 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US11648347 | Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient | Apr 06, 2034 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US5006528 | Carbostyril derivatives |
Apr 20, 2015
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US5006528 | Carbostyril derivatives |
Oct 20, 2014
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit |
US5006528 (Pediatric) | Carbostyril derivatives |
Apr 20, 2015
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US7807680 | Controlled release sterile injectable aripiprazole formulation and method | Oct 19, 2024 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8030313 | Controlled release sterile injectable aripiprazole formulation and method | Oct 19, 2024 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8338427 | Methods for administering aripiprazole | Mar 15, 2025 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8338428 | Methods for administering aripiprazole |
Aug 06, 2023
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8399469 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | Jun 29, 2025 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8722679 | Controlled release sterile injectable aripiprazole formulation and method | Oct 19, 2024 | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8759351 | Methods for administering aripiprazole |
Aug 06, 2023
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US8993761 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Maintena Kit | US9089567 | Method of treating cognitive impairments and schizophrenias |
Jan 28, 2022
(Expired) | Otsuka Pharm Co Ltd |
| Abilify Mycite Kit | US10097388 | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | Sep 19, 2034 | Otsuka |
| Abilify Mycite Kit | US10441194 | Ingestible event marker systems | Jul 26, 2029 | Otsuka |
| Abilify Mycite Kit | US10517507 | Communication system with enhanced partial power source and method of manufacturing same | Jun 13, 2032 | Otsuka |
| Abilify Mycite Kit | US11229378 | Communication system with enhanced partial power source and method of manufacturing same | Jul 11, 2031 | Otsuka |
| Abilify Mycite Kit | US11464423 | In-body power source having high surface area electrode | Sep 15, 2030 | Otsuka |
| Abilify Mycite Kit | US11476952 | Pharma-informatics system | Apr 28, 2026 | Otsuka |
| Abilify Mycite Kit | US7053092 | 5-HT1a receptor subtype agonist |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify Mycite Kit | US7978064 | Communication system with partial power source | Sep 14, 2026 | Otsuka |
| Abilify Mycite Kit | US8017615 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Jun 16, 2024
(Expired) | Otsuka |
| Abilify Mycite Kit | US8114021 | Body-associated receiver and method | Jun 21, 2030 | Otsuka |
| Abilify Mycite Kit | US8258962 | Multi-mode communication ingestible event markers and systems, and methods of using the same | Nov 25, 2030 | Otsuka |
| Abilify Mycite Kit | US8545402 | Highly reliable ingestible event markers and methods for using the same | Apr 27, 2030 | Otsuka |
| Abilify Mycite Kit | US8547248 | Implantable zero-wire communications system | Dec 18, 2030 | Otsuka |
| Abilify Mycite Kit | US8580796 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify Mycite Kit | US8642760 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify Mycite Kit | US8674825 | Pharma-informatics system | Apr 09, 2029 | Otsuka |
| Abilify Mycite Kit | US8718193 | Active signal processing personal health signal receivers | Dec 05, 2029 | Otsuka |
| Abilify Mycite Kit | US8759350 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | Mar 02, 2027 | Otsuka |
| Abilify Mycite Kit | US8847766 | Pharma-informatics system | Mar 29, 2030 | Otsuka |
| Abilify Mycite Kit | US8945005 | Controlled activation ingestible identifier | Aug 19, 2029 | Otsuka |
| Abilify Mycite Kit | US8956288 | In-body power source having high surface area electrode | Jul 06, 2029 | Otsuka |
| Abilify Mycite Kit | US8961412 | In-body device with virtual dipole signal amplification | Nov 17, 2030 | Otsuka |
| Abilify Mycite Kit | US9060708 | Multi-mode communication ingestible event markers and systems, and methods of using the same | Mar 05, 2029 | Otsuka |
| Abilify Mycite Kit | US9089567 | Method of treating cognitive impairments and schizophrenias |
Jan 28, 2022
(Expired) | Otsuka |
| Abilify Mycite Kit | US9119554 | Pharma-informatics system | Dec 16, 2028 | Otsuka |
| Abilify Mycite Kit | US9125939 | Carbostyril derivatives and mood stabilizers for treating mood disorders | Jul 28, 2026 | Otsuka |
| Abilify Mycite Kit | US9149577 | Body-associated receiver and method | Dec 15, 2029 | Otsuka |
| Abilify Mycite Kit | US9258035 | Multi-mode communication ingestible event markers and systems, and methods of using the same | Mar 05, 2029 | Otsuka |
| Abilify Mycite Kit | US9268909 | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device | Oct 15, 2033 | Otsuka |
| Abilify Mycite Kit | US9270503 | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | Sep 19, 2034 | Otsuka |
| Abilify Mycite Kit | US9320455 | Highly reliable ingestible event markers and methods for using the same | Dec 15, 2031 | Otsuka |
| Abilify Mycite Kit | US9359302 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Sep 25, 2022
(Expired) | Otsuka |
| Abilify Mycite Kit | US9387182 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
Dec 25, 2023
(Expired) | Otsuka |
| Abilify Mycite Kit | US9433371 | In-body device with virtual dipole signal amplification | Sep 15, 2029 | Otsuka |
| Abilify Mycite Kit | US9444503 | Active signal processing personal health signal receivers | Nov 19, 2027 | Otsuka |
| Abilify Mycite Kit | US9577864 | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance | Oct 03, 2033 | Otsuka |
| Abilify Mycite Kit | US9787511 | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | Sep 19, 2034 | Otsuka |
| Abilify Mycite Kit | US9941931 | System for supply chain management | Nov 04, 2030 | Otsuka |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Aripiprazole Generics
Several generic applications have been filed for Aripiprazole. The first generic version for Aripiprazole was by Alembic Pharmaceuticals Ltd and was approved on Apr 28, 2015. And the latest generic version is by Lupin Inc and was approved on Mar 18, 2024.
Given below is the list of companies who have filed for Aripiprazole generic.
1. LUPIN
Lupin Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
| 10MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
| 5MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
| 30MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
| 20MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
| 2MG | tablet | Prescription | ORAL | AB | Mar 18, 2024 |
2. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Nov 1, 2023 |
3. LANNETT CO INC
Lannett Co Inc has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Aug 14, 2015 |
4. UNICHEM
Unichem Laboratories Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
| 5MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
| 30MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
| 10MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
| 15MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
| 20MG | tablet | Prescription | ORAL | AB | Dec 1, 2021 |
5. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 7 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML
(reference standard) | solution | Prescription | ORAL | AA | Aug 14, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
| 30MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
| 20MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
| 15MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
| 10MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
| 2MG | tablet | Prescription | ORAL | AB | Jun 17, 2016 |
6. VISTAPHARM
Vistapharm Inc has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Vistapharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Dec 26, 2019 |
7. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 3 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 2, 2023 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 2, 2023 |
| 2MG | tablet | Prescription | ORAL | AB | Oct 2, 2023 |
8. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
| 30MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
| 15MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Oct 8, 2015 |
9. APOTEX
Apotex Inc has filed for 7 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 30MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 10MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Jul 24, 2015 |
| 1MG/ML | solution | Prescription | ORAL | AA | Sep 30, 2015 |
10. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Apr 28, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 10MG
(reference standard) | tablet, orally disintegrating | Prescription | ORAL | AB | Apr 28, 2015 |
| 20MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 30MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
11. TORRENT
Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 15MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 20MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 30MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
12. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
| 15MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
| 30MG | tablet | Discontinued | ORAL | N/A | Apr 28, 2015 |
13. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
| 20MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
| 2MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
| 5MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
| 30MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2019 |
14. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
| 20MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
| 15MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
| 2MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
| 10MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
| 30MG | tablet | Prescription | ORAL | AB | Dec 7, 2016 |
15. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Oct 25, 2022 |
16. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 20MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 15MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 10MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 5MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 28, 2015 |
17. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
| 30MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
| 10MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
| 15MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
| 5MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
| 2MG | tablet | Prescription | ORAL | AB | Sep 12, 2016 |
18. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Sep 29, 2016 |
| 30MG | tablet | Prescription | ORAL | AB | Sep 29, 2016 |
| 20MG | tablet | Prescription | ORAL | AB | Sep 29, 2016 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Apr 18, 2018 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Apr 18, 2018 |
| 5MG | tablet | Prescription | ORAL | AB | Sep 29, 2016 |
19. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
| 15MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
| 10MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
| 5MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
| 20MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
| 30MG | tablet | Prescription | ORAL | AB | Dec 4, 2017 |
20. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
| 15MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
| 20MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
| 30MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
| 2MG | tablet | Prescription | ORAL | AB | Oct 7, 2016 |
21. RUBICON
Rubicon Research Private Ltd has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Oct 27, 2022 |
22. MYLAN
Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
| 2MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
| 10MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
| 15MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
| 20MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
| 30MG | tablet | Discontinued | ORAL | N/A | Sep 19, 2018 |
23. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | May 23, 2017 |
| 5MG | tablet | Prescription | ORAL | AB | May 23, 2017 |
| 2MG | tablet | Prescription | ORAL | AB | May 23, 2017 |
| 30MG | tablet | Prescription | ORAL | AB | May 23, 2017 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Dec 11, 2017 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Dec 11, 2017 |
24. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Aripiprazole. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | solution | Prescription | ORAL | AA | Jan 29, 2019 |
25. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Breckenridge.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
| 2MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
| 5MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
| 10MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
| 30MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
| 15MG | tablet | Prescription | ORAL | AB | Jan 9, 2017 |
26. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
| 2MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
| 5MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
| 10MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
| 20MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
| 30MG | tablet | Prescription | ORAL | AB | Feb 21, 2019 |
27. SQUARE PHARMS
Square Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Aripiprazole. Given below are the details of the strengths of this generic introduced by Square Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Aug 28, 2018 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | N/A | Aug 28, 2018 |
| 30MG | tablet, orally disintegrating | Prescription | ORAL | N/A | Aug 28, 2018 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Aug 28, 2018 |